Brazil Metered Dose Inhaler Devices Market Outlook to 2023

Brazil Metered Dose Inhaler Devices Market Outlook to 2023


  Request for Sample Report
  Request A Quote

Executive Summary

Brazil Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalData's new report, "Brazil Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the Brazil Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the Brazil Metered Dose Inhaler Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 What Is This Report About? 4

2.2 Metered Dose Inhaler Devices Market Segmentation 4

2.3 Definitions of Markets Covered in the Report 4

3 Metered Dose Inhaler Devices Market, Brazil 5

3.1 Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), 2009-2016 5

3.2 Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), 2016-2023 6

3.3 Metered Dose Inhaler Devices Market, Brazil, Volume (Units), 2009-2016 7

3.4 Metered Dose Inhaler Devices Market, Brazil, Volume (Units), 2016-2023 8

3.5 Metered Dose Inhaler Devices Market, Brazil, Average Price ($), 2009-2023 9

3.6 Metered Dose Inhaler Devices Market, Brazil, Distribution Share by Revenue ($m), 2015-2016 10

3.7 Metered Dose Inhaler Devices Market, Brazil, Company Share by Revenue ($m), 2016 11

4 Overview of Key Companies in Brazil, Metered Dose Inhaler Devices Market 13

4.1 GlaxoSmithKline Plc 13

4.1.1 Company Overview 13

4.2 Boehringer Ingelheim GmbH 13

4.2.1 Company Overview 13

4.3 AstraZeneca Plc 13

4.3.1 Company Overview 13

4.4 Merck & Co Inc 13

4.4.1 Company Overview 13

5 Appendix 14

5.1 Research Methodology 15

5.1.1 Coverage 15

5.1.2 Secondary Research 15

5.1.3 Primary Research 16

5.1.4 Company Share Analysis 16

5.1.5 Distribution Share Analysis 16

5.1.6 Benchmarking 17

5.2 GlobalData Consulting 17

5.3 Contact Us 18

5.4 Disclaimer 18

1.2 List of Figures

Figure 1: Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), USD Constant, Historic, 2009-2016 5

Figure 2: Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), USD Constant, Forecast, 2016-2023 6

Figure 3: Metered Dose Inhaler Devices Market, Brazil, Volume (Units), Historic, 2009-2016 7

Figure 4: Metered Dose Inhaler Devices Market, Brazil, Volume (Units), Forecast, 2016-2023 8

Figure 5: Metered Dose Inhaler Devices Market, Brazil, Company Share (%) 2016 11

1.1 List of Tables

Table 1: Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), USD Constant, Historic, 2009-2016 5

Table 2: Metered Dose Inhaler Devices Market, Brazil, Revenue ($m), USD Constant, Forecast, 2016-2023 6

Table 3: Metered Dose Inhaler Devices Market, Brazil, Volume (Units), Historic, 2009-2016 7

Table 4: Metered Dose Inhaler Devices Market, Brazil, Volume (Units), Forecast, 2016-2023 8

Table 5: Metered Dose Inhaler Devices Market, Brazil, Average Price ($), Historic, 2009-2016 9

Table 6: Metered Dose Inhaler Devices Market, Brazil, Average Price ($), Forecast, 2016-2023 9

Table 7: Metered Dose Inhaler Devices Market, Brazil, Distribution Share by Revenue ($m), USD Constant, 2015-2016 10

Table 8: Metered Dose Inhaler Devices Market, Brazil, Company Share by Revenue ($m), USD Constant, 2016 12

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

GlaxoSmithKline Plc

Boehringer Ingelheim GmbH

AstraZeneca Plc

Merck & Co Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license
Single User License
USD 4995 INR 359240
Site License
USD 9990 INR 718481
Corporate User License
USD 14985 INR 1077721

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com